Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;37(10):108611.
doi: 10.1016/j.jdiacomp.2023.108611. Epub 2023 Sep 6.

Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study

Affiliations

Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study

Ninna Hahn Tougaard et al. J Diabetes Complications. 2023 Oct.

Abstract

Aims: To investigate vitamin D deficiency as a risk marker for complications in individuals with type 1 and type 2 diabetes.

Methods: A cohort study including 1448 adults with type 1 and 770 with type 2 diabetes. Individuals in the decile with lowest vitamin D level were classified as vitamin D deficient. Outcomes based on medical records and registers included mortality, major adverse cardiovascular event (MACE), heart failure, a composite kidney endpoint, albuminuria progression and sight-threatening eye disease. Risk in individuals with vitamin D deficiency was compared to the remaining using adjusted Cox proportional hazards models.

Results: Vitamin D deficiency was associated with higher risk of MACE (adjusted hazard ratio (HR): 2.6; 95 % confidence interval (CI): 1.3-5.2) in type 1, but not in type 2 diabetes. Risk of heart failure was higher in individuals with vitamin D deficiency in both cohorts (HR (95%CI): 16 (4.8-50) in type 1 and 2.4 (1.1-5.5) in type 2 diabetes). Vitamin D deficiency was not associated with development of microvascular complications or mortality.

Conclusions: Vitamin D deficiency was a risk marker for MACE and heart failure in type 1 and for heart failure in type 2 diabetes, but not for microvascular complications or all-cause mortality.

Keywords: Complications of diabetes; Type 1 diabetes; Type 2 diabetes; Vascular complications; Vitamin D deficiency.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest N.H.T. has no conflicts of interest. T.W.H. owns shares in Novo Nordisk A/S. P.R. has received research support and personal fees from AstraZeneca Bayer and Novo Nordisk, and personal fees from Astellas, Abbott, Boehringer Ingelheim, Eli Lilly, Gilead, Mundipharma, Sanofi, and Vifor; all fees are given to Steno Diabetes Center Copenhagen.

LinkOut - more resources